From: Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
 | Panobinostat |  | G0/G1 | S | G2/M |
---|---|---|---|---|---|
MDA-MB-157 | - | 24 h | 61.72 | 21.68 | 16.59 |
 | + | 24 h | 64.3 | 10.83 | 24.87 |
 | - | 72 h | 52.21 | 25.53 | 22.26 |
 | + | 72 h | 54.14 | 9.48 | 36.37 |
MDA-MB-231 | - | 24 h | 86.74 | 6.03 | 7.23 |
 | + | 24 h | 33.04 | 0.5 | 66.46 |
 | - | 72 h | 57.05 | 24.7 | 18.25 |
 | + | 72 h | 37.75 | 2.33 | 59.92 |
MDA-MB-468 | - | 24 h | 54.07 | 30.29 | 15.64 |
 | + | 24 h | 51.55 | 17.01 | 31.44 |
 | - | 72 h | 53.45 | 34.81 | 11.74 |
 | + | 72 h | 52.67 | 16.78 | 30.55 |
BT-549 | - | 24 h | 37.66 | 26.57 | 35.77 |
 | + | 24 h | 39.76 | 8.61 | 51.63 |
 | - | 72 h | 36.42 | 27.08 | 36.49 |
 | + | 72 h | 42.93 | 3.95 | 53.13 |